Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Ribera

Showing results (121-130 of 136) with videos related to

Pageof 14
Sort By:
The Journal of Antimicrobial Chemotherapy|August 8, 2018
Individual patient data meta-analysis of randomized controlled trials of dual therapy with a boosted PI plus lamivudine for maintenance of virological suppression: GeSIDA study 9717J A Perez-Molina, F Pulido, S Di Giambenedetto, et al.
The New England Journal of Medicine|February 15, 2001
A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection. Grupo de Estudio del SIDA 04/98J C Lopez Bernaldo de Quiros, J M Miro, J M Peña, et al.
HIV Clinical Trials|March 11, 2011
Late initiation of HAART among HIV-infected patients in Spain is frequent and related to a higher rate of virological failure but not to immigrant statusJ A Pérez-Molina, I Suárez-Lozano, A Del Arco, et al.
HIV Medicine|May 17, 2021
Low frequency of cytomegalovirus (CMV) disease despite high prevalence of CMV viraemia in patients with advanced HIV infection: a clinical and immunological 48-week follow-up studyA Albasanz-Puig, P Suanzes, J Esperalba, et al.
Sexually Transmitted Infections|November 7, 2008
Recently acquired HIV infection in Spain (2003-2005): introduction of the serological testing algorithm for recent HIV seroconversionA Romero, V González, M Granell, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 4, 2000
Thrice-weekly sulfadiazine-pyrimethamine for maintenance therapy of toxoplasmic encephalitis in HIV-infected patients. Spanish Toxoplasmosis Study GroupD Podzamczer, J M Miró, E Ferrer, et al.
HIV Medicine|April 5, 2023
Efficacy and safety of dolutegravir/rilpivirine in real-world clinical practice. GeSIDA study 1119R Palacios, C Gómez-Ayerbe, J L Casado, et al.
The Journal of Antimicrobial Chemotherapy|September 10, 2005
Once-daily antiretroviral therapy: Spanish Consensus StatementF Pulido, E Ribera, S Moreno, et al.
HIV Medicine|March 30, 2010
Effect of simplification from protease inhibitors to boosted atazanavir-based regimens in real-life conditionsR Rubio, O Serrano, J Carmena, et al.
HIV Medicine|September 30, 2009
The relationship between antiretroviral prescription patterns and treatment guidelines in treatment-naïve HIV-1-infected patientsI Suarez-Lozano, P Viciana, J-R Lacalle, et al.
Pageof 14

Showing results (121-130 of 136) with videos related to

Sort By:
Pageof 14
The Journal of Antimicrobial Chemotherapy|August 8, 2018
Individual patient data meta-analysis of randomized controlled trials of dual therapy with a boosted PI plus lamivudine for maintenance of virological suppression: GeSIDA study 9717J A Perez-Molina, F Pulido, S Di Giambenedetto, et al.
The New England Journal of Medicine|February 15, 2001
A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection. Grupo de Estudio del SIDA 04/98J C Lopez Bernaldo de Quiros, J M Miro, J M Peña, et al.
HIV Clinical Trials|March 11, 2011
Late initiation of HAART among HIV-infected patients in Spain is frequent and related to a higher rate of virological failure but not to immigrant statusJ A Pérez-Molina, I Suárez-Lozano, A Del Arco, et al.
HIV Medicine|May 17, 2021
Low frequency of cytomegalovirus (CMV) disease despite high prevalence of CMV viraemia in patients with advanced HIV infection: a clinical and immunological 48-week follow-up studyA Albasanz-Puig, P Suanzes, J Esperalba, et al.
Sexually Transmitted Infections|November 7, 2008
Recently acquired HIV infection in Spain (2003-2005): introduction of the serological testing algorithm for recent HIV seroconversionA Romero, V González, M Granell, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 4, 2000
Thrice-weekly sulfadiazine-pyrimethamine for maintenance therapy of toxoplasmic encephalitis in HIV-infected patients. Spanish Toxoplasmosis Study GroupD Podzamczer, J M Miró, E Ferrer, et al.
HIV Medicine|April 5, 2023
Efficacy and safety of dolutegravir/rilpivirine in real-world clinical practice. GeSIDA study 1119R Palacios, C Gómez-Ayerbe, J L Casado, et al.
The Journal of Antimicrobial Chemotherapy|September 10, 2005
Once-daily antiretroviral therapy: Spanish Consensus StatementF Pulido, E Ribera, S Moreno, et al.
HIV Medicine|March 30, 2010
Effect of simplification from protease inhibitors to boosted atazanavir-based regimens in real-life conditionsR Rubio, O Serrano, J Carmena, et al.
HIV Medicine|September 30, 2009
The relationship between antiretroviral prescription patterns and treatment guidelines in treatment-naïve HIV-1-infected patientsI Suarez-Lozano, P Viciana, J-R Lacalle, et al.
Pageof 14